Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 43 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Apixaban versus Warfarin in patients with atrial fibrillationGranger, C.; Alexander, J.; McMurray, J.; Lopes, R.; Hylek, E.; Hanna, M.; Al-Khalidi, H.; Ansell, J.; Avezum, A.; Atar, D.; Bahit, M.; Diaz, R.; Easton, J.; Ezekowitz, J.; Garcia, D.; Geraldes, M.; Gersh, B.; Golitsyn, S.; Goto, S.; Hermosillo, A.; et al.
2011Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610Okera, M.; Bae, K.; Bernstein, E.; Cheng, L.; Lawton, C.; Wolkov, H.; Pollack, A.; Dicker, A.; Sandler, H.; Sweeney, C.
2011Gastric emptying of a liquid nutrient meal in the critically ill: relationship between scintigraphic and carbon breath test measurementChapman, M.; Besanko, L.; Burgstad, C.; Fraser, R.; Bellon, M.; O'Connor, S.; Russo, A.; Jones, K.; Lange, K.; Nguyen, Q.; Bartholomeusz, F.; Chatterton, B.; Horowitz, M.
2011The effect of testosterone and a nutritional supplement on hospital admissions in under-nourished, older peoplePiantadosi, C.; Visvanathan, R.; Naganathan, V.; Hunter, P.; Cameron, I.; Lange, K.; Karnon, J.; Chapman, I.
2011Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohortNikpour, M.; Hissaria, P.; Byron, J.; Sahhar, J.; Micallef, M.; Paspaliaris, W.; Roddy, J.; Nash, P.; Sturgess, A.; Proudman, S.; Stevens, W.
2011Endogenous testosterone and mortality in men: A systematic review and meta-analysisAraujo, A.; Dixon, J.; Suarez, E.; Murad, M.; Guey, L.; Wittert, G.
2011Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapseLevis, M.; Lewis, I.
2011Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerHaller, D.; Tabernero, J.; Maroun, J.; de Braud, F.; Price, T.; Van Cutsem, E.; Hill, M.; Gilberg, F.; Rittweger, K.; Schmoll, H.
2011Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsKantarjian, H.; Giles, F.; Bhalla, K.; Pinilla-Ibarz, J.; Larson, R.; Gattermann, N.; Ottmann, O.; Hochhaus, A.; Radich, J.; Saglio, G.; Hughes, T.; Martinelli, G.; Kim, D.; Shou, Y.; Gallagher, N.; Blakesley, R.; Baccarani, M.; Cortes, J.; le Coutre, P.
2011Clinical manifestations of highly prevalent corticosteroid-binding globulin mutations in a village in Southern ItalyCizza, G.; Bernardi, L.; Smirne, N.; Maletta, R.; Tomaino, C.; Costanzo, A.; Gallo, M.; Lewis, J.; Geracitano, S.; Grasso, M.; Potenza, G.; Monteleone, C.; Brancati, G.; Ho, J.; Torpy, D.; Bruni, A.